Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +2.04% dropped 0.23% to $164.87 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.86% falling 1.89% to 4,397.94 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.98% falling 1.30% to 34,265.37. This was the stock's ninth consecutive day of losses. Johnson & Johnson closed $15.05 short of its 52-week high ($179.92), which the company achieved on August 20th.
Despite its losses, the stock outperformed some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +2.54% fell 0.32% to $394.00, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.30% fell 0.95% to $79.98, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.78% fell 2.33% to $52.79.true Trading volume (10.5 M) eclipsed its 50-day average volume of 7.5 M.